LAKE FOREST, CA--(Marketwire - February 13, 2008) - TRIMEDYNE, INC. (OTCBB: TMED) today announced the issuance of U.S. Patent No. 7,306,588 covering a new, side firing laser needle for use with its Holmium Lasers, as well as other Holmium Lasers with a compatible connector, for the interstitial (within tissue) treatment of benign prostatic hyperplasia or “BPH,” commonly called an enlarged prostate.
